Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? (2018)
- Authors:
- Cesena, Fernando H Y - Hospital Israelita Albert Einstein (HIAE)
- Laurinavicius, Antonio Gabriele - Hospital Israelita Albert Einstein (HIAE)
- Valente, Viviane A - Hospital Israelita Albert Einstein (HIAE)
- Conceição, Raquel D - Hospital Israelita Albert Einstein (HIAE)
- Santos, Raul D - Hospital Israelita Albert Einstein (HIAE)
- Bittencourt, Márcio Sommer
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1002/clc.22868
- Subjects: HIPERCOLESTEROLEMIA; COLESTEROL
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Cardiology
- ISSN: 0160-9289
- Volume/Número/Paginação/Ano: v. 41, n. 3, p. 333-338, mar. 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CESENA, Fernando H Y et al. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level?. Clinical Cardiology, v. 41, n. 3, p. 333-338, 2018Tradução . . Disponível em: https://doi.org/10.1002/clc.22868. Acesso em: 29 jan. 2026. -
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2018). Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? Clinical Cardiology, 41( 3), 333-338. doi:10.1002/clc.22868 -
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1002/clc.22868 -
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1002/clc.22868 - Incremental prognostic value of coronary artery disease and renal function on the prediction of cardiovascular events of patients evaluated by coronary computed tomography: the partners registry
- Changes in F18-flurodeoxyglucose uptake on serial cardiac positron emission tomography and left ventricular ejection fraction in patients with cardiac sarcoidosis
- Physical activity levels and hepatic steatosis: a longitudinal follow-up study in adults
- In vitro validation of coronary CT angiography for the evaluation of complex lesions
- Can coronary computed tomography angiography be the complete roadmap for chronic total occlusion management? [Editorial]
- Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment
- One year follow up of ambulatory electrocardiographic variables of patients with severe coronary artery disease undergoing coronary artery bypass graft surgery plus intramyocardial bone marrow cell injection
- Left main coronary artery disease is correlated to the clinical characteristics of stable coronary artery disease patients: a study ajusted to the coronary atherosclerotic burden
- Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia
- Coronary artery bypass surgery in diffuse advanced coronary artery disease: 1-year clinical and angiographic results
Informações sobre o DOI: 10.1002/clc.22868 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
